Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate

April 7, 2022

Harbour BioMed and AstraZeneca enter global outlicense agreement for HBM-7022

April 7, 2022

HitGen and Uppthera extend their PROTAC collaboration

April 7, 2022

Atreca announces agreement with Zymeworks and selection of new clinical candidate

April 6, 2022

Aligos selects broad-spectrum coronavirus protease inhibitor ALG-097558 for advancement

April 5, 2022

Zelluna collaborates with Etcembly and Nextera to optimize pipeline TCRs

March 31, 2022

Ube Industries and HiLung to codevelop LPA1 antagonist HL-001 for IPF

March 30, 2022

Artelo collaborates with Trinity College Dublin to better understand FABP inhibition in cancer

March 29, 2022

Insilico Medicine and EQRx enter drug discovery and development collaboration

March 25, 2022

BiondVax collaborates with Max Planck and UMG for development of NanoAbs

March 25, 2022

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...